Home 5 Position Paper 5 Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS

20/01/2025

Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS

Leggi l’articolo

← Le RBP come nuovi target terapeutici per l’osteosarcoma Cordoglio per la scomparsa del Prof. Vincenzo Lo Cascio →

Position Paper | Ultime notizie

Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS

Il Progetto #IMPACT: overview, attività e risultati di progetto

Una nuova nanoparticella peptidica per il riconoscimento selettivo degli OCs maturi

Perché iscriversi SIOMMMS

SIOMMMS

NEWS

PUBBLICAZIONI

CONGRESSI

RICERCA

Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS

Consensus statement on the use of HRT in postmenopausal womenin the management of osteoporosis by SIE, SIOMMMS and SIGO

Congressi Macroregionali SIOMMMS 2026

Linee guida sulla gestione terapeutica dell’Ipoparatiroidismo post-chirurgico nell’adulto